Daniel Hume

Director, TG Therapeutics.

Companies

Insight Digital Partners IIBoard member Oct 28, 2025 to now¹
TG TherapeuticsBoard member Jun 17, 2015 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

TG Therapeutics TGTX192,748 shares³$10.8M at $56.00Jun 12, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 12, 2025Granted 14,718 shares of TG Therapeutics³
Mar 17, 2025Gift 62,459 shares of TG Therapeutics⁴
Jun 19, 2024Granted 22,250 shares of TG Therapeutics⁵
Sep 28, 2023Granted 20,000 shares of TG Therapeutics⁶
Jul 20, 2022Granted 43,732 shares of TG Therapeutics⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInsight Digital Partners II, Board member
2
SEC EDGARTG Therapeutics, Board member
3
SEC EDGARTG Therapeutics shares after the filing of Jun 12, 2025
4
SEC EDGARForm 4 filed Mar 18, 2025
5
SEC EDGARForm 4 filed Jun 20, 2024
6
SEC EDGARForm 4 filed Sep 29, 2023
7
SEC EDGARForm 4 filed Jul 22, 2022